Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry
Biopharmaceutics & Drug Disposition · 2023
DOI: 10.1002/bdd.2371 ↗At a glance
Journal article in Biopharmaceutics & Drug Disposition, 2023. Written by Hiromi Habara and 5 co-authors. Institution: Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan. Major MEDLINE topics: Trastuzumab, Immunoconjugates, Camptothecin, Antibodies, Monoclonal, Humanized. Cited 6 times so far (Crossref); 18 references.
Abstract (original language)
Trastuzumab deruxtecan (T‐DXd, DS‐8201a) is an antibody–drug conjugate, comprising an anti‐HER2 antibody at a drug‐to‐antibody ratio of 7–8 with the topoisomerase I inhibitor DXd. In this study, the concentrations of antibody‐conjugated DXd and total antibody were determined and observed to decrease over time following intravenous administration of T‐DXd to monkeys. The drug‐to‐antibody ratio of T‐DXd also decreased in a time‐dependent manner, which reached approximately 2.5 in 21 days after administration. It was suggested that antibody‐conjugated DXd of T‐DXd was relatively stable in vivo compared with that of other reported antibody–drug conjugates.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
ORCID profiles: Hiromi Habara, Masataka Oitate
Cite
APA
Habara, H., Okamoto, H., Nagai, Y., Oitate, M., Takakusa, H., & Watanabe, N. (2023). Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.2371
Vancouver
Habara H, Okamoto H, Nagai Y, Oitate M, Takakusa H, Watanabe N. Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry. Biopharmaceutics & Drug Disposition. 2023. doi:10.1002/bdd.2371
BibTeX
@article{Habara2023,
author = {Habara, Hiromi and Okamoto, Hiromi and Nagai, Yoko and Oitate, Masataka and Takakusa, Hideo and Watanabe, Nobuaki},
title = {Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry},
journal = {Biopharmaceutics & Drug Disposition},
year = {2023},
doi = {10.1002/bdd.2371}
}
EUVIMED